SNP genotyping and analysis is used mainly as a research tool to identify genomic variations that lead to different morphological traits and can determine the health and ancestry of plants and animals. The growth of the market is attributed mainly to the increasing demand from diagnostic research, pharmacogenomics and animal breeding along with technological drivers such as reducing cost of sequencing and introduction of innovative technologies. There is an increasing opportunity in developing and developed countries for genotyping services which will be within the reach of a common man and that will represent several billion dollars worth of business since people want to understand their genetic make-up in terms of aesthetic awareness (height, weight, obesity) or for serious diseases (diabetes, cancer, cardiovascular and others).
The market products are internally affected by power of substitution since there are around 8 to 10 different efficient techniques to carry out SNP genotyping such as TaqMan, SNPlex, Microarray, MALDI-TOF etc. With the completion of the Human Genome Project, over 2 million SNP’s have been added to global databases which in turn have initiated a series of research and development projects to understand potential of developing diagnostic tests through rapid genotyping techniques. A considerable amount of revenue is spent on research to developing diagnostic products similar to companion diagnostics which would enable to give us a preview of how a genome would unfold as an individual grows older. There is a high intensity of research in food crops such as rice, wheat, oats, corn, maize and other grasses. SNP genotyping in agriculture gained acceptance long before other applications. The GeneChip Rice 44K array offered by Affymetrix is one of the most popular platforms for rice genotyping which identifies variants that impact yield. Fluidigm’s SNPtype assays have been utilized by International Rice Research Institute which holds the world’s largest ex-situ collection of rice germplasm and plays a very large role in maintaining this repository.
The global market for SNP genotyping and analysis is expected to reach USD 9,485.2 million by 2019, up from USD 2,385.2 million in 2012, growing at a CAGR of 21.8% throughout the forecast period. Geographically, North America represents the largest market because of origin of several SNP technologies, awareness and increasing demand from pharmacogenomics and animal breeding sectors. The Asia-Pacific region is expected to record the highest CAGR of 23.1% during the forecast period as improving healthcare infrastructure, increasing investments by players in emerging economies such as China and India, and a large untapped research facilities segment will also boost growth of this market segment. Life Technologies Corporation, Illumina Inc., Affymetrix Inc, Fluidigm, Sequenom and Roche are some of the key vendors operating in this market.
The increasing demand for SNP genotyping and analysis from the breeding and livestock industry has significantly driven the global SNP genotyping and analysis market in recent years. Further, the global market is likely to benefit from the rising incidence of genetic diseases and growing awareness pertaining to personalized medicine.
The research report segments the global SNP genotyping and analysis market on the basis of technologies applied, application, and regional distribution.
SNP gene-chips and microarrays, SNP by pyrosequencing, taqman allelic discrimination, MassARRAY MALDI-TOF, and AB SNPlex are the major technologies applied in the worldwide SNP genotyping and analysis market.
Pharmacogenomics and pharmaceuticals, agricultural biotechnology, diagnostic research, and breeding and livestock are the key end users of SNP genotyping and analysis.
Regionally, the global SNP genotyping and analysis market is segmented into North America, Asia Pacific, Europe, and the Rest of the World.
This research report on the global SNP genotyping and analysis market aims to provide market participants, consultants, and stakeholders a clear picture of the global scenario. The report employs various analytical tools such as Porter’s five forces, market feasibility, and SWOT analysis to present a comprehensive overview of the global market for SNP genotyping and analysis.
Overview of the SNP Genotyping and Analysis Market
The global SNP genotyping and analysis market stood at US$2.3 bn in 2012. Aided by declining prices of sequencing, a factor that has consequently trigged R&D activities in SNP genotyping and analysis, the market is likely to exhibit a CAGR of 21.80% over the period from 2013 to 2019 and reach US$9.4 bn by the end of the forecast period.
The SNP genotyping and analysis market in North America leads the global market as the region has a first-mover advantage in various significant SNP technologies. The rising awareness and augmenting demand for SNP genotyping from the animal breeding industry and the pharmacogenomics sector is likely to propel this regional market during the forecast period.
On the other hand, the Asia Pacific SNP genotyping and analysis market is projected to report the highest CAGR of 23.1% over the forecast period on account of advancements in the healthcare infrastructure in the region.
The global market for SNP genotyping and analysis is experiencing a phase of immense growth at present. However, the lack of appropriate reimbursement policies is hampering the market from growing steadily and is expected to create a severe challenge for this market over the forecast period.
Companies Mentioned in the Research Report
Affymetrix Inc., Fluidigm, Douglas Scientific LLC, Illumina Inc., PREMIER Biosoft, Life Technologies Corp., Sequenom Inc., and ThermoFisher Scientific are the key players in the global SNP genotyping and analysis market. A rise in the demand for cost-efficient genotyping solutions is likely to provide significant opportunities for the market participants during the forecast period.
Key segments of the SNP genotyping and analysis market
- SNP GeneChips and Microarrays
- Taqman Allelic Discrimination
- SNP by Pyrosequencing
- AB SNPlex
- MassARRAY MALDI-TOF
- Pharmaceuticals and Pharmacogenomics
- Diagnostic Research
- Agricultural Biotechnology
- Breeding and Animal Livestock
Major regions analyzed under this research report are:
- North America
- Asia Pacific
- Rest of the World
This report gives you access to decisive data such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key highlights of this report
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments